Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
1.190
-0.010 (-0.83%)
At close: Sep 1, 2026
Protagenic Therapeutics Company Description
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
Protagenic Therapeutics, Inc.
| Country | United States |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
Contact Details
Address: 149 Fifth Avenue New York, New York 10010 United States | |
| Phone | 212 994 8200 |
| Website | protagenic.com |
Stock Details
| Ticker Symbol | PTIX |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US74365N1037 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Garo H. Armen Ph.D. | Executive Chairman |
| William Nichols Jr. | President |
| Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer |